Sign in
FLNA Stock Price, Chart, Stats & News
Filana Therapeutics, Inc.
Save
Filana Therapeutics, Inc. (FLNA) does not currently pay a dividend.
36.14M
Market cap
–
Current P/E
151.52x
Forward P/E
FLNA chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -76.86% |
ROE | -97.94% |
D/E | – |
Interest coverage ratio | – |
FLNA valuation
P/E | – |
P/S | – |
P/B | 1.08x |
P/CF | -0.91x |
P/FCF | -0.90x |
P/OCF | -0.91x |
PEG | -0.06x |
EV multiple | -1.87x |
About
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
Similar securities
Based on sector and market capitalization
Report issue